Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?
- PMID: 23199062
- PMCID: PMC3405318
- DOI: 10.1007/s13167-010-0031-4
Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?
Abstract
Prediction and prevention of glaucoma. Neurodegenerative eye disease glaucoma is the second leading cause of blindness with estimated 67 million patients worldwide. Molecular pathomechanisms of glaucoma demonstrate both a considerable overlap with and remarkable particularities compared to other neurodegenerative disorders e.g. Alzheimer's disease. Identification of pathology-specific biomarker-sets is essential to develop advanced diagnostic approaches and personalised patients' treatment. Subcellular imaging and expression patterns in blood as the reliable platform for early/predictive glaucoma diagnosis. Following key pathways are affected in glaucoma pathology: stress response, apoptosis and DNA-repair, adhesion, blood-brain-barrier-breakdown, tissue remodelling, transcription regulation, multidrug resistance and energy metabolism.
Figures





Similar articles
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
What are the biomarkers for glaucoma?Surv Ophthalmol. 2007 Nov;52 Suppl 2:S155-61. doi: 10.1016/j.survophthal.2007.08.011. Surv Ophthalmol. 2007. PMID: 17998041 Review.
-
[The Keyrole of Multiomics in the Predictive, Preventive and Personalised Medical Approach towards Glaucoma Management].Klin Monbl Augenheilkd. 2018 Feb;235(2):146-150. doi: 10.1055/s-0044-101164. Epub 2018 Feb 15. Klin Monbl Augenheilkd. 2018. PMID: 29448284 Review. German.
-
MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer's Disease.Int J Mol Sci. 2023 Oct 5;24(19):14932. doi: 10.3390/ijms241914932. Int J Mol Sci. 2023. PMID: 37834380 Free PMC article. Review.
-
Neurodegeneration: accelerated ageing or inadequate healthcare?EPMA J. 2010 Jun;1(2):211-5. doi: 10.1007/s13167-010-0030-5. Epub 2010 Jun 29. EPMA J. 2010. PMID: 23199059 Free PMC article.
Cited by
-
New insight of metabolomics in ocular diseases in the context of 3P medicine.EPMA J. 2023 Feb 17;14(1):53-71. doi: 10.1007/s13167-023-00313-9. eCollection 2023 Mar. EPMA J. 2023. PMID: 36866159 Free PMC article. Review.
-
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Tumour Biol. 2016 Oct;37(10):12941-12957. doi: 10.1007/s13277-016-5168-x. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448308 Review.
-
Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.Metabolomics. 2018;14(6):82. doi: 10.1007/s11306-018-1377-1. Epub 2018 Jun 5. Metabolomics. 2018. PMID: 29904332 Free PMC article. Review.
-
The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.EPMA J. 2024 Feb 27;15(1):1-23. doi: 10.1007/s13167-024-00356-6. eCollection 2024 Mar. EPMA J. 2024. PMID: 38463624 Free PMC article.
-
Postmenopausal breast cancer: European challenge and innovative concepts.EPMA J. 2017 May 30;8(2):159-169. doi: 10.1007/s13167-017-0094-6. eCollection 2017 Jun. EPMA J. 2017. PMID: 28824739 Free PMC article.
References
-
- Flammer J. Glaucoma. A guide for patients. An introduction for care-providers. A quick reference. Hogrefe & Huber Publishers; 2003.
LinkOut - more resources
Full Text Sources